Where Can I Get TRT? A Guide to Safe, Legal Options

Who Qualifies for Legal TRT?

Testosterone replacement therapy is FDA-approved only for men with confirmed hypogonadism: two morning serum testosterone readings below 300 ng/dL combined with signs or symptoms such as reduced libido, fatigue, depressed mood, or loss of muscle mass. The Endocrine Society's 2018 Clinical Practice Guideline specifies that diagnosis should not rest on a single measurement alone.

The Two-Sample Diagnostic Rule

The 2018 Endocrine Society guideline recommends collecting both samples between 7 a.m. And 10 a.m., when testosterone peaks. A single low result can reflect acute illness, sleep deprivation, or assay error. Two separate low readings on different days confirm a consistent hormonal deficit rather than a transient dip. FDA prescribing guidance for testosterone products echoes this two-sample requirement on the label of testosterone cypionate.

Symptom Criteria Matter as Much as Numbers

A man with a testosterone level of 280 ng/dL but no symptoms does not automatically qualify for treatment under guideline criteria. The American Urological Association's 2018 position statement, published in the Journal of Urology, states that biochemical hypogonadism must be accompanied by clinical features before therapy begins. Symptoms alone, without a confirmed low level, are similarly insufficient.

Contraindications to Screen for Before Starting

The Endocrine Society guideline lists absolute contraindications that any prescriber must check: prostate cancer, breast cancer, an untreated severe lower urinary tract obstruction, hematocrit above 54%, and uncontrolled heart failure. A 2020 BMJ review adds that men with active venous thromboembolism should defer therapy until the thromboembolic event is fully treated.

Option 1: Primary Care Physician

Your primary care physician (PCP) is the most accessible starting point. PCPs can order the diagnostic testosterone panel, interpret results in the context of your overall health history, and write a prescription for generic testosterone cypionate or enanthate. A 2019 analysis in JAMA Internal Medicine found that PCPs account for roughly 44% of all new testosterone prescriptions in the United States.

What to Expect at the Appointment

Bring a list of symptoms and mention their duration. Your physician will order a morning total testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex-hormone-binding globulin (SHBG). If your free testosterone calculation is needed, SHBG is essential. The Endocrine Society guideline recommends measuring LH to distinguish primary from secondary hypogonadism, which affects treatment selection.

Limitations of the PCP Route

Some PCPs are less comfortable managing the ongoing monitoring that TRT requires, particularly hematocrit surveillance and PSA trending. A 2021 study in Urology found that 38% of men on TRT did not receive a PSA check in the first year of therapy. If your PCP is unfamiliar with TRT protocols, a referral to urology or endocrinology is appropriate.

Cost and Insurance Coverage

Generic testosterone cypionate (10 mL multi-dose vial, 200 mg/mL) costs $35, $75 at most retail pharmacies without insurance. Most commercial insurance plans cover it when the ICD-10 code E29.1 (testicular hypofunction) is submitted with two qualifying testosterone values. ClinicalTrials.gov NCT01602601, the Testosterone Trials (TTrials), used cypionate and enanthate as standard arms, confirming their established safety and efficacy profile.

Option 2: Urologist or Endocrinologist

A urologist or endocrinologist offers specialist-level precision. Urologists are preferred when erectile dysfunction, prostate concerns, or fertility questions complicate the picture. Endocrinologists are preferred when secondary hypogonadism (low LH with low testosterone) suggests a pituitary or hypothalamic cause requiring further imaging.

What Specialists Add That PCPs May Not

Specialists routinely measure free testosterone via equilibrium dialysis rather than relying on calculated estimates, which a 2017 paper in JCEM showed can differ from direct measurement by up to 30% in obese men. They also consider alternative therapies such as clomiphene citrate 25 to 50 mg orally three times per week, which stimulates endogenous testosterone production while preserving fertility, a critical distinction for men who want children.

The TTrials Evidence Base

The Testosterone Trials, a coordinated set of seven double-blind placebo-controlled studies (N=790 men aged 65 and older, mean baseline testosterone 232 ng/dL), demonstrated that testosterone gel 1% titrated to achieve a midrange normal level improved sexual function scores, bone mineral density, and anemia in hypogonadal older men. Results were published across multiple journals; the sexual function arm appeared in NEJM 2016. Specialists are more likely to use this evidence to calibrate target levels rather than simply pushing total testosterone above 300 ng/dL.

Fertility Preservation Before Starting

Any man under 40 should discuss sperm banking before beginning exogenous testosterone. A 2013 review in Fertility and Sterility confirmed that exogenous testosterone suppresses LH and FSH, reducing sperm counts to azoospermic levels in 65 to 75% of men within 3 to 4 months. Recovery after stopping therapy takes 6 to 18 months and is not guaranteed. Urologists who specialize in male infertility can offer concurrent human chorionic gonadotropin (hCG) 500 to 1,000 IU three times per week to partially preserve testicular function during TRT.

Option 3: Men's Health Clinics

Dedicated men's health clinics, sometimes called "Low T centers", focus exclusively on hormonal optimization, TRT management, and related concerns. They often have shorter wait times than specialist offices and staff with specific TRT protocol experience.

What Differentiates a Quality Clinic

A reputable men's health clinic will perform the same two-sample diagnostic workup the Endocrine Society requires, obtain a baseline PSA, perform a digital rectal exam or prostate ultrasound in men over 40, and provide structured 3- and 6-month monitoring visits. The AUA's testosterone position statement explicitly calls out the importance of PSA monitoring at 3 months, 6 months, and annually thereafter.

Red Flags to Avoid

Clinics that prescribe testosterone based on symptoms alone, skip the two-sample rule, fail to check hematocrit, or offer testosterone to men with PSA above 4.0 ng/mL without a urological evaluation are operating outside guideline boundaries. A 2020 analysis in Translational Andrology and Urology found that non-guideline prescribing was more common in direct-to-consumer men's health settings than in academic practices.

Formulations Commonly Offered at Clinics

Most men's health clinics stock testosterone cypionate for intramuscular or subcutaneous injection (the cheapest and most studied option), testosterone enanthate, topical gels (AndroGel 1.62%, Testim), testosterone pellets (Testopel, 75 mg each, inserted subcutaneously every 3 to 6 months), and in some states, compounded testosterone creams. FDA guidance on compounded testosterone clarifies that compounded products are not FDA-approved and carry higher variability risk than commercially manufactured formulations.

Option 4: Licensed Telehealth Platforms

Telehealth TRT has grown sharply since 2020. A licensed telehealth platform can legally prescribe testosterone in all 50 U.S. States provided the physician conducts a synchronous video or audio consult and reviews lab results before prescribing. The Ryan Haight Online Pharmacy Consumer Protection Act governs controlled-substance telemedicine, and the DEA's 2023 temporary rules (extended through 2025) allow Schedule III prescriptions via telemedicine without a prior in-person visit under specific conditions. See the DEA telemedicine rules for current requirements.

How the Telehealth Process Works

After completing an online intake, the platform orders a home blood draw through a national lab (LabCorp or Quest). A physician reviews the results, typically within 24 to 72 hours, and conducts a video consultation. If you qualify, a prescription for testosterone cypionate is sent electronically to a pharmacy or a VIPPS-accredited mail-order pharmacy. A 2022 JAMA Health Forum study found that men receiving TRT via telehealth had comparable adherence rates to those seen in in-person settings over 12 months.

Cost Comparison for Telehealth

Monthly membership fees typically range from $75 to $150 and include physician oversight and lab monitoring. Generic testosterone cypionate adds $30, $60 per month. Total out-of-pocket costs of $100, $210 per month are generally lower than men's health clinic in-person fees, which average $150, $350 per month excluding medication. Insurance reimbursement for telehealth TRT varies widely by plan.

Monitoring Obligations Still Apply

A telehealth prescriber has the same monitoring obligations as any in-person physician. Hematocrit, PSA, and testosterone levels must be checked at 3 months after initiation and at least every 6 to 12 months thereafter per Endocrine Society guidelines. Platforms that skip the 3-month lab check are out of compliance with guideline standards, regardless of their digital convenience.

Understanding TRT Formulations: Which Option Fits Your Life?

The right formulation depends on injection tolerance, lifestyle, monitoring preferences, and cost. Each delivery method reaches the same therapeutic goal, maintaining total testosterone in the 400 to 700 ng/dL range, but differs in pharmacokinetics and practical demands.

Injectable Testosterone (Cypionate and Enanthate)

Testosterone cypionate (half-life approximately 8 days) and enanthate (half-life approximately 4.5 days) are the most prescribed forms in the United States. Standard dosing is 100 to 200 mg intramuscularly every 1 to 2 weeks, or 50 to 100 mg weekly to reduce the peaks and troughs that cause mood fluctuation. Subcutaneous injection at 50 to 75 mg weekly is increasingly used for its smaller needle, reduced injection-site discomfort, and stable serum levels, as shown in a 2017 study in JCEM.

Topical Gels and Solutions

AndroGel 1.62% (testosterone 20.25 to 81 mg daily) and Testim 1% deliver testosterone transdermally. Absorption varies by skin site and individual, producing more stable daily levels than biweekly injections but requiring daily application and transfer-risk precautions. The TTrials sexual function arm used 1% testosterone gel and found statistically significant improvement in sexual desire scores (mean increase 1.9 points on an 11-point scale, P<0.001) versus placebo at 12 months, per NEJM 2016.

Pellet Therapy

Testopel pellets (75 mg testosterone each) are inserted subcutaneously into the upper buttock under local anesthesia. Typical dosing is 6 to 12 pellets every 3 to 6 months depending on body weight and metabolism. Levels are highly stable but not adjustable once inserted. Extrusion occurs in roughly 3 to 5% of insertions. A 2014 study in the Journal of Sexual Medicine reported sustained testosterone levels above 400 ng/dL in 89% of men through 6 months of pellet therapy.

Oral Testosterone (Jatenzo and Kyzarol)

The FDA approved oral testosterone undecanoate (Jatenzo) in 2019 and testosterone undecanoate (Kyzarol) in 2022. Both require twice-daily dosing with meals for optimal absorption via the lymphatic route, bypassing first-pass hepatic metabolism. FDA approval data for Jatenzo showed 87% of men achieved average testosterone in the normal range. Cost is higher than injectables, typically $400, $600 per month without insurance.

Monitoring Your TRT Safely: What Labs You Need and When

Safe TRT is not a set-it-and-forget-it prescription. A structured monitoring schedule protects against the three primary harms: polycythemia, prostate-related events, and cardiovascular changes.

Baseline Labs Before the First Dose

Before starting any formulation, your prescriber should obtain: total and free testosterone (two morning samples), LH, FSH, SHBG, complete blood count (CBC) with hematocrit, comprehensive metabolic panel, PSA, and lipid panel. Men over 40 should also have a baseline digital rectal exam. The Endocrine Society 2018 guideline specifies all of these as pre-treatment requirements.

The 3-Month Check: Most Important Visit

At 3 months, check total testosterone (timed to the midpoint of the injection cycle for injectables, or any morning for gels), hematocrit, and PSA. If hematocrit exceeds 54%, therapy should be held and dosing adjusted per the FDA testosterone labeling. If PSA rises more than 1.4 ng/mL above baseline in any 12-month period, or exceeds 4.0 ng/mL, urological referral is indicated before continuing.

Annual Monitoring Panel

After the 3-month visit, annual labs are appropriate for stable patients: testosterone, CBC, PSA, lipids, and metabolic panel. Men with prior elevated hematocrit may need a 6-month CBC. A 2010 Cochrane review of testosterone therapy found no statistically significant increase in cardiovascular events in trials under 3 years, but noted that longer-term data were limited, a reason ongoing annual monitoring matters.

TRT Safety: What the Evidence Actually Shows

Testosterone therapy carries real risks that every patient should understand before starting. The evidence base has grown considerably since the TTrials.

Polycythemia (High Red Blood Cell Count)

Testosterone stimulates erythropoiesis. Hematocrit rises above 50% in approximately 5.8% of men on injection therapy within 12 months, compared to fewer than 1% on placebo, based on data pooled in a 2018 meta-analysis in JCEM. Subcutaneous injections and gels produce lower erythrocytosis rates than intramuscular injections. Therapeutic phlebotomy (removal of 450 to 500 mL of blood) corrects polycythemia when hematocrit persistently exceeds 54%.

Cardiovascular Considerations

The TRAVERSE trial (N=5,246, median age 63.5, mean follow-up 33 months) was specifically designed to assess cardiovascular safety of testosterone gel 1.62% versus placebo in men with hypogonadism and high cardiovascular risk. Published in NEJM 2023, TRAVERSE showed testosterone was non-inferior to placebo for major adverse cardiovascular events (MACE): 7.0% in the testosterone arm vs. 7.3% in placebo (HR 0.96, 95% CI 0.83 to 1.12). The trial did find a higher rate of atrial fibrillation (3.5% vs. 2.4%) and pulmonary embolism (0.9% vs. 0.5%) in the testosterone group. These findings require discussion during the informed consent process.

Prostate Safety Data

The TRAVERSE trial also reported no significant difference in prostate cancer incidence: 0.19% in the testosterone arm vs. 0.17% in placebo over 33 months. The American Cancer Society's prostate cancer guideline does not list hypogonadism treatment as a prostate cancer cause, but recommends PSA surveillance during TRT given the biological plausibility of stimulating occult disease.

What to Do If You Have Been Refused a Prescription

Some physicians decline to prescribe TRT due to limited experience or risk aversion. This does not mean you are ineligible. Seek a second opinion from a urologist, an endocrinologist, or a board-certified men's health specialist. The American Association of Clinical Endocrinology (AACE) 2022 guidelines provide a structured algorithm that any physician can use to evaluate appropriateness of therapy.

If your testosterone level is borderline (300 to 400 ng/dL) and symptoms are mild, watchful waiting with lifestyle modification is a reasonable first step. A 2016 randomized trial published in JCEM showed that 12 weeks of resistance training raised total testosterone by a mean of 22 ng/dL in previously sedentary men with low-normal levels, though this magnitude of change is unlikely to resolve symptomatic hypogonadism alone.

Comparing Your Four Legal Pathways: A Quick Reference

| Pathway | Typical Wait | Monthly Cost (Rx only) | Monitoring Rigor | Best For | |---|---|---|---|---| | Primary Care | 1 to 3 weeks | $35, $75 | Variable | Established patients with straightforward labs | | Urologist / Endocrinologist | 3 to 8 weeks | $35, $75 | High | Complex cases, fertility concerns, borderline results | | Men's Health Clinic | 1 to 2 weeks | $150, $350 total | High (varies by clinic) | Dedicated TRT management, no existing PCP relationship | | Telehealth Platform | 2 to 5 days | $100, $210 total | Moderate, High | Convenience, lower cost, stable straightforward cases |